Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4 instead of v3.5.3, indicating a minor platform update; no study data or visible content appears to be altered.
    Difference
    0.1%
    Check dated 2026-05-16T00:12:25.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new study record version was added to the record history with minor metadata updates, alongside a platform/software revision label. No substantive change to core study information (e.g., eligibility, interventions, outcomes, availability) is indicated by the provided differences.
    Difference
    0.3%
    Check dated 2026-04-24T17:12:39.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:52:51.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added a new history entry on 2026-03-24 for Study Status. The 2026-03-23 entry shows 56 changes, and the 2026-02-27 entry was removed.
    Difference
    0.2%
    Check dated 2026-03-27T02:29:24.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added a new Revision: v3.5.0 entry and removed Revision: v3.4.3 from the history.
    Difference
    0.1%
    Check dated 2026-03-19T23:48:28.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The latest revision (v3.4.3, 2026-02-27) adds Contacts/Locations and Study Status; the prior revision (v3.4.2, 2026-01-20) was deleted.
    Difference
    0.3%
    Check dated 2026-03-05T18:58:43.000Z thumbnail image

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.